期刊
CANCER
卷 118, 期 1, 页码 134-146出版社
WILEY-BLACKWELL
DOI: 10.1002/cncr.26251
关键词
FBI-1; hepatocellular carcinoma; prognosis; chemotherapy; 5-fluorouracil; doxorubicin; p53; p21; p27
类别
资金
- National Key Technologies R&D Program of China [2001BA703B04, 2004BA703B02]
- National Keystone Basic Research Program of China [2004CB720303]
- National High Technology Research and Development Program of China [2006AA02Z4B2]
- National Science Fund for Distinguished Young Scholars of China [30328028]
- National Natural Science Foundation of China [30571826]
- Ministry of Health
- National Science and Technology Major Projects [2009ZX09103-681]
BACKGROUND: The so-called factor that binds to inducer of short transcripts-1 (FBI-1) purportedly plays an important role in tumorigenesis; however, its role in hepatocellular carcinoma (HCC) remains unknown. The objective of this study was to investigate the expression level, clinical relevance, and biologic function of FBI-1 in HCC. METHODS: Real-time quantitative reverse transcriptase-polymerase chain reaction analysis, Western blot analysis, and immunohistochemical staining were used to detect expression levels of FBI-1 and to analyze its relation to clinicopathologic parameters and to the prognosis of patients with HCC. In addition, the biologic functions of FBI-1 in regulating cell proliferation, migration, and reaction to chemotherapy were detected by using HepG2 cells and SMMC-7721 cells; subsequently, the molecular mechanism of FBI-1 also was investigated. Finally, a xenograft mouse model was used to validate the observations obtained from in vitro studies. RESULTS: Expression levels of FBI-1 messenger RNA and protein were elevated significantly in HCC tissues compared with adjacent nontumorous liver tissues (ANLTs). Increased FBI-1 expression was correlated with multiple tumor nodes, Edmondson-Steiner grade, and a poor prognosis in patients with HCC (P <.05). In vitro studies revealed that FBI-1 was capable of promoting cell proliferation (but not cell migration) by regulating the cell cycle regulation proteins p53, p21, and p27. In addition, FBI-1 could inhibit cell death induced by 5-fluorouracil or doxorubicin through suppressing the activation of p53. Consistent with the in vitro data, FBI-1 was capable of promoting cell proliferation and enhancing chemotherapy resistance of HCC in vivo. CONCLUSIONS: The current findings indicated that FBI-1 plays an important role in HCC carcinogenesis and chemotherapy tolerance, and FBI-1 may served as a novel prognostic marker and therapeutic target for HCC. Cancer 2012; 118: 134-46. (C) 2011 American Cancer Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据